Monday, July 21, 2014 - 12:30
--Specialty Drug Costs Biggest Driver of Drug --Traditional Brand-Name and Generic Drug Prices Also Rising --Consumers Face Higher Deductibles, Co-Payments and Co-Insurance Percentages
(MNI) - prices of specialty drugs that treat , rheumatoid arthritis, cancer and other diseases are leading overall U.S. consumer prescription drug costs higher, according to pharmacists, pharmacy benefit managers and industry experts.
Druggists and industry experts told MNI that traditional brand-name and generic drugs prices are also firming. Right alongside that, healthcare cost-sharing for prescription drugs continues to shift toward employees and others insured, by way of deductibles, co-payments, drug coverage exclusions and percentage coverage, also known as co-insurance. The moderating impact on costs in recent years from a wave of blockbuster brand-name drugs going generic, from
to , has faded, they said.
A pharmacy benefit management company forecasted accelerating prescription-drug cost increases in 2014 for both consumers and insurers.
continue to read here
Reality Check: US Consumer Drug Costs Climb Ever Higher
--Specialty Drug Costs Biggest Driver of Drug --Traditional Brand-Name and Generic Drug Prices Also Rising --Consumers Face Higher Deductibles, Co-Payments and Co-Insurance Percentages
Druggists and industry experts told MNI that traditional brand-name and generic drugs prices are also firming. Right alongside that, healthcare cost-sharing for prescription drugs continues to shift toward employees and others insured, by way of deductibles, co-payments, drug coverage exclusions and percentage coverage, also known as co-insurance. The moderating impact on costs in recent years from a wave of blockbuster brand-name drugs going generic, from
A pharmacy benefit management company forecasted accelerating prescription-drug cost increases in 2014 for both consumers and insurers.
continue to read here
No comments:
Post a Comment